The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Abbvie; AstraZeneca; Celldex; Eisai; Pfizer; Puma Biotechnology
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Covance/Bayer (Inst); Incyte (Inst); Lilly (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst)
Phase Ib study of heat shock protein 90 inhibitor, onalespib in combination with paclitaxel in patients with advanced, triple-negative breast cancer (NCT02474173).
 
Robert Wesolowski
Consulting or Advisory Role - Agenus; Nepa; Novartis
Research Funding - Acerta Pharma
Travel, Accommodations, Expenses - Agenus; Nepa; Novartis
 
Maryam B. Lustberg
No Relationships to Disclose
 
Raquel E. Reinbolt
No Relationships to Disclose
 
Jeffrey Bryan VanDeusen
No Relationships to Disclose
 
Sagar D. Sardesai
No Relationships to Disclose
 
Nicole Olivia Williams
No Relationships to Disclose
 
Anne M. Noonan
Consulting or Advisory Role - Helsinn Healthcare
 
Shabana Jaynul Dewani
No Relationships to Disclose
 
Ming Poi
No Relationships to Disclose
 
Debbie Wilson
No Relationships to Disclose
 
Michael R. Grever
No Relationships to Disclose
 
Julie Stephens
No Relationships to Disclose
 
Shannon Puhalla
No Relationships to Disclose
 
Aju Mathew
No Relationships to Disclose
 
William Edgar Carson
No Relationships to Disclose
 
Bhuvaneswari Ramaswamy
No Relationships to Disclose